Form 4: Amphastar Pharmaceuticals CFO William J. Peters Reports Stock Transaction
SEC Form 4 Filing
William J. Peters, CFO, EVP & Treasurer of Amphastar Pharmaceuticals, Inc., reports a transaction involving the withholding of shares to cover tax liabilities related to vested restricted stock units.
Summary
- On May 19, 2024, William J. Peters, CFO, EVP & Treasurer of Amphastar Pharmaceuticals, Inc., had 387 shares of common stock withheld to cover tax obligations.
- The shares were withheld at a price of $43.48 per share.
- Following the transaction, Peters directly owns 97,268 shares of Amphastar Pharmaceuticals, Inc.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of a routine transaction (tax withholding). It doesn't indicate positive or negative sentiment about the company's prospects.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to track management's sentiment and actions regarding their company's stock.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a standard tax withholding procedure.
Key Dates
| Date | Description |
|---|---|
| 05/19/2024 | Date of stock transaction (tax withholding) |
| 05/21/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.